Craig Orofino
Physician Assistant · Plainview, NYNPI 1922268887
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by AbbVie at 57.1% of the total. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 735 payments — averaging $58.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Amgen$5K
- Johnson & Johnson$3K
- Mallinckrodt Hospital Products Inc.$2K
- Incyte Corporation$1K
- UCB, Inc.$945
- plus $6K from 25 others
What the payments were for
- Speaking & faculty fees$20,65948%
- Travel & lodging$1,1773%
- Food & beverage$20,22647%
- Education$7062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 130 | $24,406 |
| Amgen(2 entities) | 165 | $5,362 |
| Johnson & Johnson(2 entities) | 98 | $2,865 |
| Mallinckrodt Hospital Products Inc. | 51 | $2,081 |
| Incyte Corporation | 9 | $1,002 |
| UCB, Inc. | 41 | $945 |
| Pfizer | 58 | $793 |
| ANI Pharmaceuticals, Inc. | 22 | $762 |
| E.r. Squibb & Sons, L.L.C. | 14 | $571 |
| Novartis | 29 | $523 |
| GSK | 20 | $477 |
| AstraZeneca(2 entities) | 18 | $461 |
| Lilly USA, LLC | 14 | $309 |
| Pacira Therapeutics, Inc. | 5 | $277 |
| Intra-sana Laboratories | 2 | $276 |
| Boehringer Ingelheim | 12 | $269 |
| Janssen Scientific Affairs, LLC | 2 | $250 |
| Organon | 10 | $220 |
| Aurinia Pharma U.S., Inc. | 4 | $169 |
| Genentech USA, Inc. | 9 | $168 |
| Neurocrine Biosciences, Inc. | 1 | $125 |
| Octapharma USA, Inc. | 4 | $94 |
| Sanofi | 4 | $81 |
| Radius Health, Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Bioventus LLC | 1 | $24 |
| Vertex | 1 | $20 |
| Sandoz | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$19,103
- Skyrizi$3,459
- KRYSTEXXA$1,488
- OPZELURA$994
- ACTHAR$991
- SIMPONI ARIA$893
- Tremfya$768
- EVENITY$351
- PURIFIED CORTROPHIN GEL$341
- Reltone 200 Mg$276
- Reltone 400 Mg$276
- GLYCATE$276
- ORENCIA$273
- Otezla$260
- STELARA$250
- Bimzelx$249
- Tavneos$243
- INGREZZA$125
- SAPHNELO$125
- PENNSAID$120
How this compares
$42,767 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 80 | $207,815 |
| RinvoqUpadacitinib | 15 | $115,534 |
| Diclofenac Potassium | 14 | $105,492 |
| Cosentyx Sensoready PenSecukinumab | 11 | $70,148 |
| Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag | 12 | $47,243 |
| Hydroxychloroquine Sulfate | 150 | $7,240 |
| MethotrexateMethotrexate Sodium | 135 | $4,006 |
| Leflunomide | 42 | $2,968 |
| Gabapentin | 147 | $2,383 |
| Prednisone | 443 | $2,364 |
| Duloxetine Hcl | 113 | $2,090 |
| Colchicine | 12 | $2,049 |
| Celecoxib | 94 | $1,681 |
| Allopurinol | 116 | $812 |
| Methylprednisolone | 66 | $500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $24,406 | $115,53415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Plainview
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.